Ciclopirox Patent Expiration

Ciclopirox is Used for treating interdigital tinea pedis and tinea corporis caused by certain types of fungi. It was first introduced by Medimetriks Pharmaceuticals Inc in its drug Loprox on Dec 30, 1982. Other drugs containing Ciclopirox are Ciclopirox, Penlac. 21 different companies have introduced drugs containing Ciclopirox.


Ciclopirox Patents

Given below is the list of patents protecting Ciclopirox, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Ciclopirox US7018656 Antimycotic gel with high active substance release Sep 05, 2018

(Expired)

Alvogen
Loprox US7981909 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis Sep 16, 2017

(Expired)

Bausch
Loprox US8227490 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis Sep 16, 2017

(Expired)

Bausch
Ciclopirox US7026337 Antimycotic gel having high active compound release Nov 21, 2016

(Expired)

Alvogen



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ciclopirox's patents.

Given below is the list recent legal activities going on the following patents of Ciclopirox.

Activity Date Patent Number
Patent litigations
Expire Patent 07 May, 2018 US7026337
Maintenance Fee Reminder Mailed 20 Nov, 2017 US7026337
Change in Power of Attorney (May Include Associate POA) 27 Mar, 2009 US7026337
Correspondence Address Change 24 Mar, 2009 US7026337
Change in Power of Attorney (May Include Associate POA) 18 Sep, 2007 US7026337
Recordation of Patent Grant Mailed 11 Apr, 2006 US7026337
Patent Issue Date Used in PTA Calculation 11 Apr, 2006 US7026337
Issue Notification Mailed 22 Mar, 2006 US7026337
Dispatch to FDC 09 Mar, 2006 US7026337
Application Is Considered Ready for Issue 27 Jan, 2006 US7026337


Ciclopirox's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ciclopirox Generic API Manufacturers

Several generic applications have been filed for Ciclopirox. The first generic version for Ciclopirox was by Fougera Pharmaceuticals Inc and was approved on Aug 6, 2004. And the latest generic version is by Encube Ethicals Private Ltd and was approved on Apr 5, 2018.

Given below is the list of companies who have filed for Ciclopirox generic, along with the locations of their manufacturing plants worldwide.